BioWorld MedTech

Oct. 10, 2012

Financings roundup: LoneStar Heart completes $20M milestone-based fund

Washington roundup: IsoAid warned over validation procedures, sterilization issues

Deals roundup:Boston Scientific to acquire Rhythmia for up to $265M

Agreements/contracts : RI Research awarded FAIR project, valued at $5.8 million

HIT roundup: SMS to provide support for DoD and VA iEHR initiative

Edwards' third quarter sales weak, but rebound expected

Edwards Lifesciences (Irvine, California) reported unexpectedly weak third quarter sales, but both the company and analysts say near-term catalysts should boost fourth quarter and 2013 sales. Read More

FDA grants Integra expanded indication for spine application

Today's news in brief

BioWorld

ADPD 2026: Can we prevent dementia? Scientists quantify it

BioWorld

Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...

Illustration of Alzheimer's disease in the brain

ADPD 2026: Three inflection points to target Alzheimer’s disease

BioWorld Science

A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...

News in brief

BioWorld Asia

BioWorld Asia briefs for March 17, 2026

SERCA inhibitor from Sumitomo shows promise for MSA-C treatment